Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
47 hedge funds and large institutions have $8.49M invested in Applied Genetic Technologies Corporation in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 19 reducing their positions, and 12 closing their positions.
2,300% more call options, than puts
Call options by funds: $72K | Put options by funds: $3K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 53 → 47 (-6)
42% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 12
47% less capital invested
Capital invested by funds: $16.2M → $8.49M (-$7.69M)
74% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$167K |
| 2 |
CG
Colony Group
Boston,
Massachusetts
|
+$83.8K |
| 3 |
HF
HRT Financial
New York
|
+$62K |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
+$57.2K |
| 5 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$17.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
-$2.09M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$440K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$217K |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$216K |
| 5 |
BlackRock
New York
|
-$173K |
AGTC Hedge Fund Activity: Q2 2022 in Review
47 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q2 2022, worth a combined $8.49M — down 47% from $16.2M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of AGTC and 7 opened new positions — a net loss of 5 holders — while 19 trimmed existing stakes and 5 added.
The largest buyer was Renaissance Technologies, adding an estimated $167K. The largest seller was Cantor Fitzgerald, cutting an estimated $2.09M.
- 47 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q2 2022, down from 53 in Q1 2022.
- Funds reported $8.49M of Applied Genetic Technologies Corporation stock for Q2 2022, down 47% quarter-over-quarter.
- 7 funds opened new Applied Genetic Technologies Corporation positions in Q2 2022 and 12 closed out, a net change of -5 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q2 2022 was Renaissance Technologies, an estimated $167K added.
- The largest Applied Genetic Technologies Corporation seller in Q2 2022 was Cantor Fitzgerald, an estimated $2.09M sold.
Based on aggregated 13F filings for Q2 2022.